Skip to Content
The UK will soon be home to two of the most hi-tech train centres in Europe, as completion approaches for the new Three Bridges and Hornsey depots. The two depots, constructed with an investment of over £300 million by Siemens, will house the Siemens-built Class 700 Desiro City trains, which will start operating on Govia Thameslink Railway’s (GTR) Thameslink and Great Northern services from spring 2016.
At Traffex 2015, Siemens unveils a new approach to network management utilising its new Service Operations Centre (SOC) – an operational traffic management and support service that brings together the company’s existing Field Service Contact Centre, Systems Support and its Poole-based Consultancy Services team into one location.
The manufacture of the new Siemens-built, Desiro City trains for Thameslink – known as the Class 700 - is well under way, with the first train due to arrive in the UK later this year. Over 200 (out of a total of 1,140) Class 700 body shells have now been manufactured with a total of six trains completed to date.
Siemens will unveil a new cycle detection system at Traffex next month. WiMag Cycle Detection uses in-ground, low-power, wireless detectors and microwave radar technology to identify and count bicycles of all types, including those constructed from carbon fibre. The solution complements the company’s existing WiMag, loop and radar detection solutions.
Siemens has been selected by Southend-on-Sea Borough Council (SOSBC) to provide a new hosted traffic management service operating real-time Urban Traffic Control (UTC) including SCOOT adaptive control. The new seven year contract will see the migration of the current system to a new hosted Stratos solution to control traffic signal equipment across the town at 50 junctions and pedestrian crossings.
The University of Cambridge has been awarded £25 million in funding by the Medical Research Council (MRC) to invest in a range of revolutionary technologies for experimental medicine. This enables a major investment in innovative neuroimaging technologies to identify the causes of dementia plus speed up diagnosis and treatment. This includes ultra-high power MR imaging technology such as the MAGNETOMTM 7T imaging system from Siemens Healthcare. Designed to identify small changes in the structure, function and chemistry of the brain even before dementia starts, the technology will help to ensure the university remains one of the world leaders in clinical and cognitive neuroscience research. e
A new two-year traffic monitoring partnership between Siemens and OptaSense, a QinetiQ company, has been agreed to further explore the performance and potential commercial deployment of OptaSense Distributed Acoustic Sensing (DAS), a fully networked traffic monitoring solution for the UK traffic industry.